Growth Metrics

Resmed (RMD) Receivables (2016 - 2025)

Resmed's Receivables history spans 16 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Receivables rose 15.45% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, up 15.45%, while the annual FY2025 figure was $990.7 million, 13.16% up from the prior year.
  • Receivables reached $1.0 billion in Q4 2025 per RMD's latest filing, up from $958.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.0 billion in Q4 2025 to a low of $534.2 million in Q1 2022.
  • Average Receivables over 5 years is $756.9 million, with a median of $731.0 million recorded in 2023.
  • Peak YoY movement for Receivables: decreased 4.59% in 2021, then soared 33.31% in 2023.
  • A 5-year view of Receivables shows it stood at $550.7 million in 2021, then grew by 26.27% to $695.4 million in 2022, then rose by 9.91% to $764.3 million in 2023, then grew by 18.66% to $907.0 million in 2024, then rose by 15.45% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for RMD's Receivables are $1.0 billion (Q4 2025), $958.4 million (Q3 2025), and $990.7 million (Q2 2025).